Vanguard Fiduciary Trust
PASG icon

Vanguard Fiduciary Trust’s Passage Bio PASG Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.2K Hold
17,049
– – ﹤0.01% 3772
2026
Q1 		$134K Buy
+17,049
New +$176K ﹤0.01% 3643

Other funds holding PASG

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM

Vanguard Fiduciary Trust's PASG Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Passage Bio (PASG) position steady in Q2 2026 at 17,049 shares worth $83.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.

Vanguard Fiduciary Trust first reported a position in PASG in Q1 2026 and has held it in 2 quarters since. The position peaked at $134K in Q1 2026. 30 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Vanguard Fiduciary Trust held 17,049 shares of Passage Bio worth $83.2K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Passage Bio share count unchanged in Q2 2026.
  • Passage Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3772 holding.
  • Vanguard Fiduciary Trust first reported a position in Passage Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Passage Bio position peaked at $134K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.